Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

American Journal of Transplantation - Tập 10 Số 3 - Trang 464-471 - 2010
B. Sis1,2, Michael Mengel1,2, Mark Haas3, Robert B. Colvin4, Philip F. Halloran1, Lorraine C. Racusen5, Kim Solez2, William M. Baldwin6, Erika Bracamonte7, Verena Broecker8, Borja G. Cosío9, A J Demetris10, Cinthia B. Drachenberg11, Gunilla Einecke12, James M. Gloor9, Denis Glotz13, Edward S. Kraus14, Claire Legendre15, Helen Liapis16, Roslyn B. Mannon17, Brian J. Nankivell18, Volker Nickeleit19, John C. Papadimitriou11, Parmjeet Randhawa10, Heinz Regele20, Karine Renaudin21, L. Leonardo Rodriguez22, Daniel Serón23, Surya V. Seshan24, Manikkam Suthanthiran25, B Wa̧sowska5, Pedram Argani14, Adriana Zeevi10
1Alberta Transplant Applied Genomics Centre, Division of Nephrology & Immunology, Department of Medicine, University of Alberta, Edmonton, Canada
2Department of Laboratory Medicine and Pathology
3Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA
4Department of Pathology, Harvard Medical School and Massachusetts General Hospital, Boston, MA;
5Department of Pathology, Johns Hopkins University, Baltimore, Md.
6Department of Immunology, Lerner Research Institute, Cleveland Clinic, OH
7Department of Pathology, University of Arizona, Tucson, AZ
8Department of Pathology, Hannover Medical School, Germany
9Division of Nephrology and Hypertension, The Mayo Foundation and Clinic, Rochester, NY
10Division of Transplantation Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, PA
11Department of Pathology, University of Maryland, Baltimore, MD
12Department of Nephrology, Hannover Medical School, Germany
13Department of Nephrology, Hospital Saint‐Louis, Paris, France
14Department of Medicine, John Hopkins University, Baltimore, MD
15Université Paris Descartes & Service de Transplantation, Hôpital Necker, Paris, France
16Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
17Division of Nephrology, University of Alabama, Birmingham, AL
18Center for Transplant Research and Renal Research, Westmead Hospital Sydney, Australia
19Department of Laboratory Medicine and Pathology, University of North Carolina, Chapel Hill, NC
20Institute for Pathology, University of Vienna, Vienna, Austria
21Department of Pathology, CHU Hotel Dieu, Nantes, France
22Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH
23Department of Nephrology, Hospital Vall D'Hebron, Barcelona, Spain
24Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
25Division of Nephrology, Department of Medicine, Weill Medical College of Cornell University, New York, NY

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kissmeyer‐Nielsen, 1966, Hyperacute rejection of kidney allografts associated with pre‐existing humoral antibodies against donor cells, Lancet, 2, 662, 10.1016/S0140-6736(66)92829-7

Morris, 1968, Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man, Transplant, 6, 392, 10.1097/00007890-196805000-00010

Halloran, 1990, The significance of the anti‐class I antibody response. I. Clinical and pathologic features of anti‐class I‐mediated rejection, Transplant, 49, 85, 10.1097/00007890-199001000-00019

Halloran, 1992, The significance of the anti‐class I response II. Clinical and pathologic features of renal transplants with anti‐class I‐like antibody, Transplant, 53, 550, 10.1097/00007890-199203000-00011

Feucht, 1991, Vascular deposition of complement‐split products in kidney allografts with cell‐mediated rejection, Clin Exp Immunol, 86, 464, 10.1111/j.1365-2249.1991.tb02954.x

Mauiyyedi, 2001, Chronic humoral rejection: identification of antibody‐mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries, J Am Soc Nephrol, 12, 574, 10.1681/ASN.V123574

Regele, 2002, Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection, J Am Soc Nephrol, 13, 2371, 10.1097/01.ASN.0000025780.03790.0F

Uehara, 2007, Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis, Am J Transplant, 7, 57, 10.1111/j.1600-6143.2006.01599.x

Minami, 2006, C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats, Am J Transplant, 6, 923, 10.1111/j.1600-6143.2006.01281.x

Hirohashi, 2008, Antibody mediated, complement independent transplant arteriopathy in mice, Am J Transplant, 8, 179

Rahimi, 2004, Non‐complement‐ and complement‐activating antibodies synergize to cause rejection of cardiac allografts, Am J Transplant, 4, 326, 10.1111/j.1600-6143.2004.00334.x

Murata, 2007, Synergistic deposition of C4d by complement‐activating and non‐activating antibodies in cardiac transplants, Am J Transplant, 7, 2605, 10.1111/j.1600-6143.2007.01971.x

Locke, 2009, Proinflammatory events are associated with significant increases in breadth and strength of HLA‐specific antibody, Am J Transplant, 9, 2136, 10.1111/j.1600-6143.2009.02764.x

Breimer, 2009, Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation, Transplant, 87, 549, 10.1097/TP.0b013e3181949d4e

Lachmann, 2009, Anti‐human leukocyte antigen and donor‐specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts, Transplant, 87, 1505, 10.1097/TP.0b013e3181a44206

Morales‐Buenrostro, 2008, A single human leukocyte antigen‐antibody test after heart or lung transplantation is predictive of survival, Transplant, 85, 478, 10.1097/TP.0b013e3181605cd9

Burns, 2008, Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation, Am J Transplant, 8, 2684, 10.1111/j.1600-6143.2008.02441.x

Rother, 2008, C5 blockade with conventional immunosuppression induces long‐term graft survival in presensitized recipients, Am J Transplant, 8, 1129, 10.1111/j.1600-6143.2008.02222.x

Michaels, 2003, Humoral rejection of human organ transplants, Springer Semin Immunopathol, 25, 119, 10.1007/s00281-003-0139-x

Tan, 2009, Correlation of donor‐specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody‐mediated rejection, Am J Transplant, 9, 2075, 10.1111/j.1600-6143.2009.02748.x

Stewart, 2005, Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection, J Heart Lung Transplant, 24, 1710, 10.1016/j.healun.2005.03.019

Sis, 2009, Endothelial gene expression in kidney transplants with alloantibody indicates antibody‐mediated damage despite lack of C4d staining, Am J Transplant, 9, 2312, 10.1111/j.1600-6143.2009.02761.x

Nimmerjahn, 2007, Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity, Proc Natl Acad Sci USA, 104, 8433, 10.1073/pnas.0702936104

Yamakuchi, 2007, Antibody to human leukocyte antigen triggers endothelial exocytosis, Proc Natl Acad Sci USA, 104, 1301, 10.1073/pnas.0602035104

Lee, 2007, The involvement of FcR mechanisms in antibody‐mediated rejection, Transplant, 84, 1324, 10.1097/01.tp.0000287457.54761.53

Macgregor, 2009, The absence of FcRIII results in increased pro‐inflammatory response in FcRIII KO cardiac allograft recipients, Am J Transplant, 9, 481

Morrell, 2008, In vivo platelet‐endothelial cell interactions in response to major histocompatibility complex alloantibody, Circ Res, 102, 777, 10.1161/CIRCRESAHA.107.170332

Fukami, 2009, Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection, J Immunol, 182, 309, 10.4049/jimmunol.182.1.309

Sis, 2007, Transplant glomerulopathy, late antibody‐mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause, Am J Transplant, 7, 1743, 10.1111/j.1600-6143.2007.01836.x

Gloor, 2007, Transplant glomerulopathy: Subclinical incidence and association with alloantibody, Am J Transplant, 7, 2124, 10.1111/j.1600-6143.2007.01895.x

Haas, 2007, Subclinical acute antibody‐mediated rejection in positive crossmatch renal allografts, Am J Transplant, 7, 576, 10.1111/j.1600-6143.2006.01657.x

Sis, 2009, Endothelial stress accelerates graft loss in kidneys with transplant glomerulopathy despite lack of C4D staining, Am J Transplant, 9, 349

Wavamunno, 2007, Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies, Am J Transplant, 7, 2757, 10.1111/j.1600-6143.2007.01995.x

Haas, 2009, C4d deposition without rejection correlates with reduced early scarring in ABO‐incompatible renal allografts, J Am Soc Nephrol, 20, 197, 10.1681/ASN.2008030279

Gloor, 2006, Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation, Am J Transplant, 6, 1841, 10.1111/j.1600-6143.2006.01416.x

Mannon, 2006, Therapeutic targets in the treatment of allograft fibrosis, Am J Transplant, 6, 867, 10.1111/j.1600-6143.2006.01261.x

Mengel, 2009, Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts, Am J Transplant, 9, 169, 10.1111/j.1600-6143.2008.02462.x

El Zoghby, 2009, Identifying specific causes of kidney allograft loss, Am J Transplant, 9, 527, 10.1111/j.1600-6143.2008.02519.x

Einecke, 2009, Antibody‐mediated microcirculation injury is the major cause of late kidney transplant failure, Am J Transplant, 9, 2520, 10.1111/j.1600-6143.2009.02799.x

Reeve, 2009, Diagnosing rejection in renal transplants: a comparison of molecular‐ and histopathology‐based approaches, Am J Transplant, 9, 1802, 10.1111/j.1600-6143.2009.02694.x

Kayler, 2008, Acute renal allograft rejection: Diagnostic significance of focal peritubular capillary C4d, Transplant, 85, 813, 10.1097/TP.0b013e3181669194

Kedainis, 2009, Focal C4d+ in renal allografts is associated with the presence of donor‐specific antibodies and decreased allograft survival, Am J Transplant, 9, 812, 10.1111/j.1600-6143.2009.02555.x

Mengel, 2009, Scoring total inflammation is superior to the current banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts, Am J Transplant, 9, 1859, 10.1111/j.1600-6143.2009.02727.x

Sis, 2006, Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor‐treated renal allograft recipients, Am J Transplant, 6, 1444, 10.1111/j.1600-6143.2006.01302.x

Solez, 2008, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x

Anglicheau, 2008, A simple clinico‐histopathological composite scoring system is highly predictive of graft outcomes in marginal donors, Am J Transplant, 8, 2325, 10.1111/j.1600-6143.2008.02394.x

Mueller, 2007, Microarray analysis of rejection in human kidney transplants using pathogenesis‐based transcript sets, Am J Transplant, 7, 2712, 10.1111/j.1600-6143.2007.02005.x

Drachenberg, 2004, Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load, Am J Transplant, 4, 2082, 10.1046/j.1600-6143.2004.00603.x

Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x

Thông tin
Thông tin xuất bản

American Journal of Transplantation

Tập 10 Số 3

464-471

Thông tin tác giả